Business
Profit forecast upgrade obesity diabetes drug sales rises
Novo Nordisk has raised its forecast for the second time this year, reflecting a rosier outlook for obesity and diabetes drug sales. The move…
Novo Nordisk has raised its forecast for the second time this year, reflecting a rosier outlook for obesity and diabetes drug sales. The move…
A worsening earnings picture is darkening the outlook for Chinese equities, with investors wary that Lunar New Year spending may not be enough to…